Literature DB >> 10517499

Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero.

G Almeida-Porada1, A W Flake, H A Glimp, E D Zanjani.   

Abstract

Although promising, clinical and experimental efforts at in utero hematopoietic stem cell (HSC) transplantation currently are limited by minimal donor cell engraftment and lack of early donor cell expression after transplantation. We reasoned that cotransplantation of stromal elements (ST) might condition the fetal microenvironment for the engraftment of donor HSC and facilitate precocious bone marrow (BM) hematopoiesis. In this study we cotransplanted sheep ST, derived from adult or fetal BM, with either adult or fetal HSC, into preimmune fetal sheep. We analyzed donor cell chimerism in BM and peripheral blood and compared levels of chimerism achieved with recipients of HSC alone. In all experimental groups, stromal cotransplantation markedly increased the level of peripheral blood donor cell expression at 60 days after transplantation relative to controls. Adult BM-derived stroma cotransplanted with adult HSC provided the highest levels of circulating donor cells, whereas fetal-derived stroma was less effective. In addition, ST cotransplantation resulted in increased donor cell engraftment in the BM and led to significantly increased levels of donor hematopoiesis for over 30 months after transplant. Cotransplantation of stroma may represent a valuable clinical strategy for optimal application of in utero HSC transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10517499     DOI: 10.1016/s0301-472x(99)00090-9

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  23 in total

Review 1.  Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

Authors:  Todd Meyerrose; Scott Olson; Suzanne Pontow; Stefanos Kalomoiris; Yunjoon Jung; Geralyn Annett; Gerhard Bauer; Jan A Nolta
Journal:  Adv Drug Deliv Rev       Date:  2010-10-13       Impact factor: 15.470

Review 2.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

3.  Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation.

Authors:  Nak Gyun Chung; Dae Chul Jeong; Soo Jeong Park; Byung Ock Choi; Bin Cho; Hack Ki Kim; Chung Sik Chun; Jong Ho Won; Chi Wha Han
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

4.  In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems.

Authors:  Courtney Quinn; Alan W Flake
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 5.  Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.

Authors:  Charalampos Pontikoglou; Frédéric Deschaseaux; Luc Sensebé; Helen A Papadaki
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

6.  In utero transplantation: Disparate ramifications.

Authors:  John S Pixley; Esmail D Zanjani
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

Review 7.  Concise review: hitting the right spot with mesenchymal stromal cells.

Authors:  Jakub Tolar; Katarina Le Blanc; Armand Keating; Bruce R Blazar
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

8.  Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood.

Authors:  Chun-Juan Guo; Ying Gao; Di Hou; Dong-Yan Shi; Xiang-Min Tong; Dan Shen; Yong-Mei Xi; Jin-Fu Wang
Journal:  World J Stem Cells       Date:  2011-05-26       Impact factor: 5.326

9.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

Review 10.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.